about
In-vivo biodistribution and safety of 99mTc-LLP2A-HYNIC in canine non-Hodgkin lymphomaEffects of imputation on correlation: implications for analysis of mass spectrometry data from multiple biological matrices.Evaluation of two methods to estimate and monitor bird populations.Predicting resource utilization in burn treatment.Predicting mortality from burns: the need for age-group specific models.Affinity of the alpha4-beta1 integrin-targeting peptide LLP2A to canine lymphoma.The influence of Shc proteins on life span in mice.Ultrasonographic thickening of the muscularis propria in feline small intestinal small cell T-cell lymphoma and inflammatory bowel diseaseEvaluation of glycomic profiling as a diagnostic biomarker for epithelial ovarian cancer.Routine CSF analysis in coccidioidomycosis is not required.Computed tomographic pneumocolonography in normal dogs.Does wound eversion improve cosmetic outcome?: Results of a randomized, split-scar, comparative trial.Electronic alerts for triage protocol compliance among emergency department triage nurses: a randomized controlled trial.Urinary acylcarnitines are altered in human kidney cancer.Systemic Metabolomic Changes in Blood Samples of Lung Cancer Patients Identified by Gas Chromatography Time-of-Flight Mass SpectrometryAssessment of 3 Bowel Preparation Protocols for Computed Tomography Pneumocolonography in Normal Dogs.Kidney tumor biomarkers revealed by simultaneous multiple matrix metabolomics analysisMultivariate two-part statistics for analysis of correlated mass spectrometry data from multiple biological specimens.The Influence of Dietary Fat Source on Life Span in Calorie Restricted Mice.Metabolomic markers of altered nucleotide metabolism in early stage adenocarcinomaShc proteins influence the activities of enzymes involved in fatty acid oxidation and ketogenesis.Differential N-Glycosylation Patterns in Lung Adenocarcinoma TissueA validity review of the National Burn Repository.Chip-based nLC-TOF-MS is a highly stable technology for large-scale high-throughput analysesOxytocin and vasopressin in children and adolescents with autism spectrum disorders: sex differences and associations with symptomsPerfusion and Volume Response of Canine Brain Tumors to Stereotactic Radiosurgery and RadiotherapyEffect of screening abdominal ultrasound examination on the decision to pursue advanced diagnostic tests and treatment in dogs with neurologic diseaseOverdiagnosis of Clostridium difficile Infection in the Molecular Test Era.Burn center volume makes a difference for burned childrenA competing risk analysis for hospital length of stay in patients with burnsMealtime, temporal, and daily variability of the human urinary and plasma metabolomes in a tightly controlled environment.Accounting for undetected compounds in statistical analyses of mass spectrometry 'omic studies.Redefining the outcomes to resources ratio for burn patient triage in a mass casualty.Transfusion Requirement in Burn Care Evaluation (TRIBE): A Multicenter Randomized Prospective Trial of Blood Transfusion in Major Burn Injury.Not all patients meet the 1day per percent burn rule: A simple method for predicting hospital length of stay in patients with burn.Urine metabolomic analysis identifies potential biomarkers and pathogenic pathways in kidney cancer.Serum phosphatidylethanolamine levels distinguish benign from malignant solitary pulmonary nodules and represent a potential diagnostic biomarker for lung cancer.Omega-3 fatty acids partially revert the metabolic gene expression profile induced by long-term calorie restriction.Real-Time Prediction for Burn Length of Stay Via Median Residual Hospital Length of Stay Methodology.Protein-Specific Differential Glycosylation of Immunoglobulins in Serum of Ovarian Cancer Patients.
P50
Q27305229-B85EDCFB-FA65-403A-A4FF-52F4920FE1D1Q31047935-DBB6774F-018B-426E-BB58-4A75D780E527Q33363550-F49C8360-B888-49C3-B25E-96471F02EA73Q33926666-BDCEDE75-6C76-4929-9607-748D22EE92F3Q34084363-9E29CA01-B14B-4EDA-B653-C3C6F1F254D9Q34158053-DF9638B6-3FB8-496B-B612-3E466CC4D1FDQ34229666-E6BED969-C7F3-41C4-B840-FBBAC35B6A07Q34257427-F7215B7C-C1F1-415A-8053-D6B670C7C4E0Q34503577-37ACB95E-475C-4AF3-A74F-AC03E696DC36Q34745529-4D480DE1-B47B-4E5D-987A-5E3F63BBF6F1Q35534925-5D7DE001-CBD9-493A-8D6C-B1E9BE86CE7AQ35548835-7D028DB3-F00B-4A9B-92B5-78C2C5222ECCQ35564264-F0165E12-9AA0-4193-922D-CF85B07E19F5Q35673207-6A011193-A33D-4A0B-B47B-7F8B1395F38EQ35829888-2B03630E-D145-4350-A74C-A8F9F2AD9890Q36094506-673E73F5-6206-45A8-807A-4DBC499D8D79Q36101138-E6A1CCAE-DF57-4B12-A186-701EA6CC4C49Q36122695-6B911339-D813-4EC0-8BA4-D4E8FD0046F6Q36181410-37C2FD0B-4D34-46B4-A392-BD0380C37CD6Q36201742-66CB843B-7167-4AD2-99A3-5D782E04C592Q36233571-FBBDC202-B5CE-4EE9-BA83-7B437C972651Q36278033-3F9DD92E-E85F-4F64-9BB7-FCD19CE0C210Q36595033-A2ACC02C-B0F1-4221-AE77-D62D52270DE2Q36808014-4C3E8C04-BA90-4BD1-B5ED-45F0D65F1FE6Q36854203-52DB1921-4FCD-4BCB-B49E-21491C71C0E7Q36902053-23708CA8-B04A-477B-A341-C23B3B94607EQ36974883-BB4769A7-B210-4A9D-9CC2-77865B50B196Q37103258-DBDA4ABD-2BC7-47FF-B3FC-EA2E96F8DECAQ37114667-13189273-E6BE-46EB-A69C-8DA257342298Q37141577-F8E86E59-DA31-4E59-9C5D-1D8DD4BC830BQ37514271-CBB79359-42F7-4937-B9E7-1C537588BF69Q37528138-A90687A9-FF28-4447-87CE-9AC9D46AB2E2Q37604178-94A8A699-A131-4C12-9D71-64C442A9BAFDQ38374203-FC9A08CB-286B-437C-8231-7B6156AD7E43Q39045103-FB242DF5-CA14-47DE-9B1C-6A2C326B36E4Q39586577-DA8D7B71-D1CF-4F67-96BD-E557D0EE4BC4Q39898932-D9EA04AA-3664-4AD2-886D-B9EB1D3B9081Q39997993-8F828DB1-CE79-4C21-AE37-91459AC941E2Q41036454-0451CE33-FA25-40BD-BA62-C09E99F7C8F9Q42124029-AADBE0D5-7701-4A57-BE6F-F7C2A664162A
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Sandra L. Taylor
@ast
Sandra L. Taylor
@en
Sandra L. Taylor
@es
Sandra L. Taylor
@nl
Sandra L. Taylor
@sl
type
label
Sandra L. Taylor
@ast
Sandra L. Taylor
@en
Sandra L. Taylor
@es
Sandra L. Taylor
@nl
Sandra L. Taylor
@sl
prefLabel
Sandra L. Taylor
@ast
Sandra L. Taylor
@en
Sandra L. Taylor
@es
Sandra L. Taylor
@nl
Sandra L. Taylor
@sl
P106
P1153
36984012800
P21
P31
P496
0000-0001-7811-812X